PROQR THERAPEUTICS NV

ProQR Therapeutics NV pioneers biotech solutions for rare genetic disorders, trading near $2.22 on Nasdaq with a $303 M market cap and a promise of breakthrough therapies.

ProQR Therapeutics NV is a Dutch biotech company pioneering innovative treatments for genetic disorders, with a promising future and significant potential to transform the lives of patients worldwide.